These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8631557)

  • 1. Loss of heterozygosity of chromosome 3p sequences is an infrequent event in endometrial cancer.
    Arlt MF; Herzog TJ; Mutch DG; Goodfellow PJ
    Gynecol Oncol; 1996 Feb; 60(2):308-12. PubMed ID: 8631557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma.
    Ogasawara S; Maesawa C; Tamura G; Satodate R
    Cancer Res; 1995 Feb; 55(4):891-4. PubMed ID: 7850805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer.
    Manderson EN; Presneau N; Provencher D; Mes-Masson AM; Tonin PN
    Mol Carcinog; 2002 Jun; 34(2):78-90. PubMed ID: 12112314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High resolution analysis of chromosome 3p alterations in cervical carcinoma.
    Larson AA; Kern S; Curtiss S; Gordon R; Cavenee WK; Hampton GM
    Cancer Res; 1997 Sep; 57(18):4082-90. PubMed ID: 9307297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers.
    Peiffer SL; Herzog TJ; Tribune DJ; Mutch DG; Gersell DJ; Goodfellow PJ
    Cancer Res; 1995 May; 55(9):1922-6. PubMed ID: 7728760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DCC genetic alterations and expression in endometrial carcinoma.
    Ronnett BM; Burks RT; Cho KR; Hedrick L
    Mod Pathol; 1997 Jan; 10(1):38-46. PubMed ID: 9021725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alteration mapping on chromosome 7 in primary breast cancer.
    Bièche I; Khodja A; Driouch K; Lidereau R
    Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary.
    Sato N; Tsunoda H; Nishida M; Morishita Y; Takimoto Y; Kubo T; Noguchi M
    Cancer Res; 2000 Dec; 60(24):7052-6. PubMed ID: 11156411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detailed genetic and physical mapping of tumor suppressor loci on chromosome 3p in ovarian cancer.
    Fullwood P; Marchini S; Rader JS; Martinez A; Macartney D; Broggini M; Morelli C; Barbanti-Brodano G; Maher ER; Latif F
    Cancer Res; 1999 Sep; 59(18):4662-7. PubMed ID: 10493522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed deletion mapping of chromosome arm 3p in breast cancers: a 2-cM region on 3p14.3-21.1 and a 5-cM region on 3p24.3-25.1 commonly deleted in tumors.
    Matsumoto S; Kasumi F; Sakamoto G; Onda M; Nakamura Y; Emi M
    Genes Chromosomes Cancer; 1997 Nov; 20(3):268-74. PubMed ID: 9365834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelotype analysis of esophageal adenocarcinomas: evidence for the involvement of sequences on the long arm of chromosome 4.
    Hammoud ZT; Kaleem Z; Cooper JD; Sundaresan RS; Patterson GA; Goodfellow PJ
    Cancer Res; 1996 Oct; 56(19):4499-502. PubMed ID: 8813147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma.
    Ittmann MM
    Prostate; 1996 May; 28(5):275-81. PubMed ID: 8610052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of chromosome 3p deletions in human epithelial ovarian tumors.
    Lounis H; Mes-Masson AM; Dion F; Bradley WE; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 1998 Nov; 17(18):2359-65. PubMed ID: 9811467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The loss of heterozygosity on the short arm of chromosome 3 in renal carcinoma].
    Maestro de las Casas ML; del Barco Barriuso V; Moreno Sierra J; Izquierdo López L; Sanz Casla MT; Zanna I; Redondo González E; Chicharro Almarza J; Fernández Pérez C; Resel Estévez L
    Arch Esp Urol; 1999; 52(1):3-9. PubMed ID: 10101881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cluster of allele losses within a 2.5 cM region of chromosome 10 in high-grade invasive bladder cancer.
    Kagan J; Liu J; Stein JD; Wagner SS; Babkowski R; Grossman BH; Katz RL
    Oncogene; 1998 Feb; 16(7):909-13. PubMed ID: 9484782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma.
    Chino K; Esumi M; Ishida H; Okada K
    J Urol; 1999 Aug; 162(2):614-8. PubMed ID: 10411097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity at chromosome 9q22-31 is a frequent and early event in ovarian tumors.
    Byrom J; Mudaliar V; Redman CW; Jones P; Strange RC; Hoban PR
    Int J Oncol; 2004 May; 24(5):1271-7. PubMed ID: 15067351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
    el-Naggar AK; Batsakis JG; Wang G; Lee MS
    Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.